In 2023, you supported the submission of a NUB application to the InEK for your technology in order to secure a NUB fee?
The application has not been approved by InEK and received status 2 or status 4?
Now the question arises as to how you should react to this:
- Does it make sense to resubmit a NUB application?
- Does the NUB application have to be adapted for this purpose?
- Are there any other measures that can be taken to support the remuneration for the technology?
Healthcare Heads has extensive experience in securing reimbursement and supporting market access for innovative medical technologies on the German healthcare market.
Read more here.
Author: Healthcare Heads GmbH
Phone: +49 431 800 1470
E-Mail: info@healthcareheads.com